
The current study included 4,770 participants in the placebo arm of the Prostate Cancer Prevention Trial, which evaluated the effects of the drug finasteride. The current subjects were free of symptoms of Benign prostatic hyperplasia (BPH, or enlargement of the prostate) at the beginning of the study, and received annual screenings for the condition over a seven year average period. Food frequency questionnaires were administered to assess dietary intake one year following enrollment.Continue Reading
No comments:
Post a Comment